Por: ABC News Business May 02, 2023
Pfizer beat first-quarter forecasts as revenue took an expected dip, but the drugmaker predicted a sales rally later this year. The pharmaceutical giant said Tuesday that total revenue dropped 29% in quarter, as sales tumbled for its market-leading COVID-19 vaccine, Comirnaty. The vaccine brought in $3 billion in the first three months of this year compared to more than $13 billion in last year's first quarter, when virus cases were... + full article
Associated Press USA Business May 02, 2023
Pfizer topped Wall Street expectations Tuesday even as revenue shrank and sales of its top-selling COVID-19 vaccine crumbled as expected in the first quarter. Comirnaty vaccine sales fell 77% to $3 billion in the first three months of the year, compared with more than $13... + más
FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5 | RTTNews
RTTNews USA Health March 15, 2023
The U.S. Food and Drug Administration has authorized bivalent Pfizer-BioNTech covid-19 vaccine as booster dose for certain children 6 months through 4 years of age.In a statement, the regulator said it has amended the emergency use authorization or EUA of the Pfizer-BioNTech... + más
Amid pathetic uptake, FDA green lights confusing COVID vaccine update for kids | Ars Technica
Newsweek USA Business February 06, 2023
Pfizer's involvement with the 2023 Grammy Awards sparked speculation online, with some viewers wondering how much input the pharmaceutical company had.The annual music ceremony was held at the Crypto.com Arena in Los Angeles, California on Sunday night, with Beyoncé... + más
Here's how to watch the 2023 Grammys on iPhone, iPad, Apple TV, and more | 9to5Mac
Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy. | MarketWatch
MarketWatch USA Business February 04, 2023
Pfizer stock, too, has fallen out of favor, along with other Covid plays. At $44, it’s down 15% this year, making it one of the worst performers in the index. And it’s 30% below its late 2021 peak, badly trailing the rest of the drug group. Now looks like the time to buy... + más
Fact Check: Were the Grammys sponsored by Pfizer? | Newsweek
Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history | CNBC
CNBC USA Health December 06, 2022
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Dado Ruvic Reuters has rejected allegations made by rival that its Covid-19 vaccine is a copy, accusing the Boston biotech company of... + más
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
CNBC USA Health November 02, 2022
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021.John Thys AFP Getty Images... + más
Pfizer raises 2022 earnings guidance, beats third-quarter expectations | CNBC
Pfizer climbs on strong Q3 results, raised outlook | MarketWatch
About iurex | Privacy Policy | Disclaimer |